Medicine
Journavx 50 mg tablet
Journavx 50 mg tablet is a prescription medicine containing Suzetrigine for oral use, marketed by Vertex Pharmaceuticals, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians.
Availability
Export supply from India to licensed buyers
Typical lead time
On request
Counted from payment and complete documents
Shipping
Ambient
Store at 68°F to 77°F (20°C to 25°C), excursions permitted to 59°F to 86°F…
Key facts
- Active ingredient (INN)
- Suzetrigine
- Brand
- Journavx
- Strength
- 50 mg
- Dosage form
- Tablet
- Route
- Oral
- Packs
- 30 tablets, 100 tablets, 10 blister pack and 4 more
- Marketing authorisation holder
- Vertex Pharmaceuticals
- Manufacturers
- Vertex PharmaceuticalsSportpharm
- Origin register
- US FDA, United States
- Storage
- Store at 68°F to 77°F (20°C to 25°C), excursions permitted to 59°F to 86°F (15°C to 30°C).
- Cold chain
- Not required on record
- Prescription status
- Prescription only
- Controlled substance
- Not recorded as controlled
- HS code (indicative)
- 3004.90Indicative only. Your customs broker confirms the final tariff code.
- Marketing category
- marketed
- Marketed since
- 30 January 2025
- Identifiers
- RxCUI 2704833, 2704839DailyMed set ID d229cf71-96ec-4206-960b-d56fafc250ac, f0976da4-1d20-4517-945c-b60ed2f41c12NDC 85766-243, 51167-548Application NDA219209
Record updated 12 November 2026
Documents available
Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.
No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.
Packs
| Pack | Code | Labeler | Marketed since |
|---|---|---|---|
| 30 tablet, film coated in 1 bottle | 51167-548-30 | Vertex Pharmaceuticals | 30 January 2025 |
| 100 tablet, film coated in 1 bottle | 51167-548-31 | Vertex Pharmaceuticals | 30 January 2025 |
| 10 blister pack in 1 carton / 10 tablet, film coated in 1 blister pack | 51167-548-34 | Vertex Pharmaceuticals | 30 January 2025 |
| 100 tablet, film coated in 1 bottle | 85766-243-01 | Sportpharm | 13 July 2026 |
| 20 tablet, film coated in 1 bottle | 85766-243-20 | Sportpharm | 21 July 2026 |
| 30 tablet, film coated in 1 bottle | 85766-243-30 | Sportpharm | 13 July 2026 |
| 10 blister pack in 1 carton / 10 tablet, film coated in 1 blister pack | 85766-243-99 | Sportpharm | 13 July 2026 |
Status by register
Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.
| Register | Status | Source |
|---|---|---|
| US FDA | Listed, marketed | Source record for this pageChecked 12 November 2026 |
| US FDA | First approved 30 January 2025 | Drugs@FDA |
| EU (EMA) | Not recorded | — |
| India (CDSCO) | Not yet confirmed against CDSCO approval lists | — |
| United States | Registered | US FDA (NDC directory, openFDA)Checked 12 November 2026 |
Import route
Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.
Import guides are available for 25 countries. Pick one to see its route summary.
BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides
Clinical summary
Suzetrigine is a sodium channel blocker indicated for the treatment of moderate to severe acute pain, including postoperative pain, in adults. It is available as tablets for oral use. MedsAcross supplies Suzetrigine for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.
Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review
Read about SuzetrigineFor healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.
Data sources
- DailyMed label record · Checked 12 November 2026
- JOURNAVX prescribing information (Vertex Pharmaceuticals) · U.S. National Library of Medicine, DailyMed
Need Journavx 50 mg tablet for your hospital or patient?
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.